SAN DIEGO -- Administering fecal microbiota via colonoscopy instead of rectally prevented recurrence of Clostridium difficile (C. diff) for up to 2 months with no major safety signals, according to a ...

Data presented at Digestive Disease Week (DDW) 2025 demonstrated safety and treatment success in patients treated for recurrent C. Diff infection with REBYOTA administered by colonoscopy Data also ...

Why The Research Is Interesting: Clostridium difficile infection (CDI) causes inflammation of the colon and severe diarrhea. The infection occurs when normal gut bacteria are disrupted. Fecal ...

The Food and Drug Administration has approved a fecal microbiota pill to treat recurrent infections caused by Clostridium difficile (C. diff), an antibiotic-resistant bacterium deemed an urgent threat ...

The National Institute for Health and Care Excellence (NICE) has recommended faecal microbiota transplant (FMT) as a treatment option for those with recurrent Clostridium difficile (C diff) infections ...

November 5, 2020 at 2:04 a.m. | Updated November 5, 2020 at 2:05 a.m. by Michael Roizen, M.D. , Mehmet Oz, M.D. In the texting lexicon, the poop emoji can be used to convey bathroom behavior, crappy ...

An innovative treatment for patients with Clostridium difficile infection (CDI) which uses transplanted gut bacteria to treat the infection, is a more effective and more cost-efficient treatment than ...

ATLANTA -- Mortality rates from Clostridioides difficile-related infections have fallen steadily since 2016, but the condition continues to take an uneven lethal toll based on sex, demographics, and ...